TAMBURIN, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 20.645
EU - Europa 17.529
AS - Asia 10.890
SA - Sud America 1.786
Continente sconosciuto - Info sul continente non disponibili 641
AF - Africa 367
OC - Oceania 64
Totale 51.922
Nazione #
US - Stati Uniti d'America 19.956
RU - Federazione Russa 5.285
IT - Italia 4.689
SG - Singapore 4.093
CN - Cina 3.152
GB - Regno Unito 2.528
BR - Brasile 1.404
FR - Francia 1.389
VN - Vietnam 1.084
HK - Hong Kong 904
SE - Svezia 807
DE - Germania 791
IE - Irlanda 639
FI - Finlandia 499
KR - Corea 414
CA - Canada 340
BD - Bangladesh 279
NL - Olanda 174
IN - India 153
ID - Indonesia 152
AR - Argentina 139
UA - Ucraina 134
TR - Turchia 115
JP - Giappone 107
MX - Messico 99
PL - Polonia 83
ES - Italia 79
ZA - Sudafrica 72
AT - Austria 70
IQ - Iraq 68
EC - Ecuador 65
NG - Nigeria 65
BE - Belgio 62
AU - Australia 57
CH - Svizzera 48
LT - Lituania 48
CR - Costa Rica 47
CO - Colombia 46
PK - Pakistan 44
CW - ???statistics.table.value.countryCode.CW??? 40
GT - Guatemala 39
IR - Iran 36
SA - Arabia Saudita 35
VE - Venezuela 35
MA - Marocco 34
CL - Cile 33
BJ - Benin 32
MY - Malesia 31
EG - Egitto 30
IL - Israele 29
TG - Togo 29
UZ - Uzbekistan 28
PH - Filippine 27
JM - Giamaica 25
KE - Kenya 25
CZ - Repubblica Ceca 23
PE - Perù 22
SV - El Salvador 22
NI - Nicaragua 21
RO - Romania 21
TT - Trinidad e Tobago 21
PT - Portogallo 20
AL - Albania 17
HN - Honduras 17
AE - Emirati Arabi Uniti 16
DZ - Algeria 16
OM - Oman 16
TN - Tunisia 15
GR - Grecia 14
PR - Porto Rico 14
EE - Estonia 13
PY - Paraguay 13
AZ - Azerbaigian 12
BG - Bulgaria 12
JO - Giordania 12
TH - Thailandia 12
UY - Uruguay 12
MT - Malta 11
BO - Bolivia 10
LV - Lettonia 10
NP - Nepal 10
ET - Etiopia 8
GP - Guadalupe 8
HU - Ungheria 8
NO - Norvegia 8
TW - Taiwan 8
CI - Costa d'Avorio 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
LB - Libano 7
BB - Barbados 6
NZ - Nuova Zelanda 6
RS - Serbia 6
SC - Seychelles 6
AM - Armenia 5
EU - Europa 5
HR - Croazia 5
PA - Panama 5
SN - Senegal 5
Totale 51.214
Città #
Ashburn 2.842
Singapore 2.160
Southend 1.932
San Jose 1.816
Moscow 1.683
Dallas 1.643
Chandler 1.463
Hong Kong 887
Woodbridge 826
Verona 735
Jacksonville 700
Council Bluffs 638
Dublin 627
Beijing 612
Ann Arbor 529
The Dalles 501
Milan 433
Houston 430
New York 357
Rome 349
Ho Chi Minh City 338
Los Angeles 295
Princeton 263
Lawrence 260
Wilmington 227
Hanoi 217
Jinan 186
Nanjing 179
São Paulo 176
Santa Clara 167
Buffalo 161
Munich 149
Atlanta 131
Shenyang 130
Helsinki 128
Redondo Beach 116
Tianjin 107
Hebei 99
Columbus 97
Jakarta 90
Seoul 90
Naples 87
Orem 85
Tokyo 85
Seattle 83
London 82
Toronto 82
Montreal 80
Bologna 79
Dong Ket 79
Zhengzhou 79
Boardman 78
Phoenix 78
Florence 72
Turku 72
Chicago 71
Frankfurt am Main 71
Denver 67
Hangzhou 67
Sindelfingen 67
Abuja 64
Changsha 64
Haikou 62
Lancaster 62
Nanchang 62
Ningbo 60
Lappeenranta 58
Turin 58
Brussels 57
Redwood City 57
San Francisco 57
Warsaw 56
Brooklyn 55
Guangzhou 55
Padova 51
Taizhou 51
Amsterdam 49
Jiaxing 49
Nuremberg 49
Redmond 47
Rio de Janeiro 44
Bari 42
Falkenstein 41
Genoa 41
Palermo 41
Norwalk 40
Shanghai 40
Willemstad 40
Enfield 39
Belo Horizonte 38
Chennai 38
Modena 38
Paris 37
Stockholm 37
Johannesburg 36
Trento 36
Catania 35
Vienna 34
Brasília 33
Cotonou 32
Totale 28.118
Nome #
Detoxification improves multidomain cognitive dysfunction in high-dose benzodiazepine abusers 2.110
TOSSINA BOTULINICA ED ELETTROSTIMOLAZIONE: CONFRONTO TRA DUE DIVERSI PROTOCOLLI DI TRATTAMENTO DELLA SPASTICITÀ. RISULTATI PRELIMINARI 1.866
LOCALIZZAZIONE DI LESIONE NELL’ICTUS CEREBRALE ED OUTCOME MOTORIO: STUDIO PROSPETTICO SU MAPPE LESIONALI DI 14 PAZIENTI TRAMITE ANALISI “VOXEL-BASED”. 790
Il morbo di Parkinson 356
Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis 310
Association between adult attention deficit/hyperactivity disorder and intravenous misuse of opioid and benzodiazepine in patients under opioid maintenance treatment: a cross-sectional multicentre study 310
Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing OnabotulinumtoxinA injection due to chronic intractable migraine? A pilot, single-blind randomized controlled trial 281
Modificazioni a livello del sistema nervoso periferico nel paziente con ictus cerebrale e spasticità di arto superiore. correlati neurofisiologici, ecografici e clinici 268
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 265
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model 257
Comparison between physical and cognitive treatment in patients with MCI and Alzheimer's disease. 256
Evaluation of Adjuvant Psychological Therapy with Clinical Hypnosis and Self-hypnosis for Pain, Anxiety and Psychosomatic Symptoms Relief, in Patients with Severe Chronic Diseases in Palliative Care 255
Abnormalities of motor cortex excitability are related to clinical symptoms in patients with cerebellar ataxia 254
Psychological Considerations in the Assessment and Treatment of Pain in Neurorehabilitation and Psychological Factors Predictive of Therapeutic Response: Evidence and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 251
Testing the performance of the imputation of MHC region in large datasets when using different reference panels 245
Abnormalities of motor cortex excitability in cerebellar ataxia. Cliniconeurophysiological correlations 244
Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence 241
Screening for adult attention deficit/hyperactivity disorder in high-dose benzodiazepine dependent patients 241
Psychological Treatments and Psychotherapies in the Neurorehabilitation of Pain: Evidences and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 235
Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus conference on Pain in Neurorehabilitation 231
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 230
Exercise training on locomotion in patients with Alzheimer's disease. A feasibility Study 228
VALUTAZIONE DELL'EFFICACIA DI UN PROTOCOLLO DI TRATTAMENTO AGOPUNTURA SUI SEGNI MOTORI DELLA MALATTIA DI PARKINSON E SUI CORRELATI DI NEUROIMAGING FUNZIONALE. STUDIO PILOTA RANDOMIZZATO CONTROLLATO 227
Abnormal cutaneomotor integration in patients with cerebellar syndromes: a transcranial magnetic stimulation study 225
Accuracy of botulinum toxin type A injection into the gastrocnemius muscle of adults with spastic equinus: Manual needle placement and electrical stimulation guidance compared using ultrasonography. 223
Combined effects of robot-assisted gait training and botulinum toxin type A on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial 223
Brain lesions and spasticity: a voxel-based lesion-symptom mapping analysis on 51 patients. 222
Pathophysiology of motor dysfunction in Parkinson’s Disease as the rationale for drug treatment and rehabilitation 221
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 219
Time for a Consensus Conference on pain in neurorehabilitation 218
Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy 216
Efficacia, sicurezza e tollerabilità della tossina botulinica A nella profilassi in pazienti con emicrania cronica: studio esplorativo di coorte su 52 pazienti 215
Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population? 215
DOES ULNAR NERVE IMPAIRMENT AT THE WRIST CONTRIBUTE TO EXTRAMEDIAN SPREAD OF SENSORY SYMPTOMS IN CARPAL TUNNEL SYNDROME? 212
VALUTAZIONE DEGLI EFFETTI DI UN TRATTAMENTO INTEGRATO ARTICOLARE E MIOFASCIALE ASSOCIATO A TOSSINA BOTULINICA IN PAZIENTI AFFETTI DA EMICRANIA CRONICA: STUDIO PILOTA RANDOMIZZATO CONTROLLATO. 212
Abnormal somatotopic arrangement of sensorimotor interactions in dystonic patients. 211
Abnormalities of short afferent inhibition of cutaneous stimulation in Parkinson's disease are reversed by dopaminergic drugs 210
A wearable system for visual cueing gait rehabilitation in Parkinson's disease: a randomized non-inferiority trial 208
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 208
Abnormal sensorimotor interactions in dystonia secondary to lesions in the somatosensory system 207
Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: a TMS study 206
Abnormalities of sensorimotor integration to transcranial magnetic stimulation in Parkinson's disease. The effect of dopaminergic drugs 205
The Association between serum cytokines and damage to large and small nerve fibers in diabetic peripheral neuropathy. 203
Determinants of quality of life in high-dose benzodiazepine misusers 203
Abnormalities of sensory processing and sensorimotor interactions in upper-limb dystonia after lesions in the somatosensory system 202
Relationship between ultrasonographic, electromyographic and clinical parameters in adult stroke patients with spastic equinus: an observational study. 201
Dissection of HLA-C gene region to investigate its association with complex traits 201
Multimorbidity in dementia: Current perspectives and future challenges 200
Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug 200
Solid grounds still needed in acupuncture clinical trials. 'Effects of motion style acupuncture treatment in acute low back pain patients with severe disability' by Shin et al. 199
Abnormalities of somatotopy of sensorimotor interactions in patients with focal dystonia 198
Abnormalities of sensorimotor interactions in dystonia secondary to lesions in the somatosensory system 196
Task-dependent modulation of excitatory and inhibitory functions within the human primary motor cortex 194
Towards a wearable system for predicting the freezing of gait in people affected by Parkinson's disease 193
QTc Prolongation in Patients with Dementia and Mild Cognitive Impairment: Neuropsychological and Brain Imaging Correlations 192
LOCALIZZAZIONE DI LESIONI NELL’ICTUS CEREBRALE E RECUPERO DELL’EMINEGLIGENZA SPAZIALE: STUDIO SPERIMENTALE IN PAZIENTI CON DANNO EMISFERICO DESTRO 191
Magnetic resonance-guided focused ultrasound unilateral thalamotomy for medically refractory essential tremor: 3-year follow-up data 190
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease 190
Long-term response of neuropathic pain to intravenous immunoglobulin in relapsing diabetic lumbosacral radiculoplexus neuropathy: a case report. 190
Median nerve small- and large-fiber damage in carpal tunnel syndrome: a quantitative sensory testing study. 189
Botulinum toxin type a injection into the gastrocnemius muscle for spastic equinus in adults with stroke: a randomized controlled trial comparing manual needle placement, electrical stimulation and ultrasonography-guided injection techniques. 189
A case of oligosymptomatic botulism. The role of single-fiber EMG in early diagnosis. 188
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 188
INTERACTION BETWEEN NEGATIVE AND POSITIVE PSYCHOPHYSICAL VARIABLES IN CARPAL TUNNEL SYNDROME 187
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 185
Pharmacological and non-pharmacological strategies in the integrated treatment of pain in neurorehabilitation. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 184
Selective atrophy of the brachialis muscle in neuralgic amyotrophy: ultrasound imaging of fascicular nerve damage 183
High-dose dependence and cognitive side effects to medical prescription of etizolam 183
A low-cost wireless body area network for human activity recognition in healthy life and medical applications 182
Intravenous immunoglobulins for the treatment of diabetic lumbosacral radiculoplexus neuropathy 182
LOCALIZZAZIONE DI LESIONI NELL’ICTUS CEREBRALE E RECUPERO DELL’EMINEGLIGENZA SPAZIALE: STUDIO SPERIMENTALE IN PAZIENTI CON DANNO EMISFERICO DESTRO 182
Stimulus-response properties of motor system in patients with cerebellar ataxia. 181
PREDICTING THE RESPONSE TO 5\% LIDOCAINE MEDICATED PLASTER IN TRIGEMINAL NEURALGIA AND TRIGEMINAL NEUROPATHIC PAIN: A CASE SERIES 181
An indoor therapeutic garden for behavioral symptoms in Alzheimer's Disease: a randomized controlled trial 181
Effect of upper limb motor rehabilitation on cognition in Parkinson's Disease: an observational study 180
NERVE ULTRASOUND FINDINGS IN A COHORT OF PATIENTS WITH MPZ-RELATED CHARCOT-MARIE-TOOTH NEUROPATHIES 180
The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment 180
The role of inflammation and immune system in neuropathic pain: will inflammatory-immune network represent a new therapeutic target in this condition? 179
Pain Contributes to Motor Symptoms in Carpal Tunnel Syndrome 179
Sensorimotor integration to cutaneous inputs in humans. The effect of the size of the receptive field. A transcranial magnetic stimulation study 179
Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first? 177
Association between severe upper limb spasticity and brain lesion location in stroke patients. 177
Central sensitization in carpal tunnel syndrome with extraterritorial spread of sensory symptoms. 175
Guillain-Barré syndrome after short-course efalizumab treatment 175
Central sensitization and sensory symptoms spread in carpal tunnel syndrome: A response to Ginanneschi and Rossi's letter on the relationship between central plastic changes and sensory symptoms in peripheral entrapment neuropathies. 175
Diagnosing and assessing pain in neurorehabilitation: from translational research to the clinical setting. Evidence and recommendations from the Italian Consensus conference on pain in neurorehabilitation 175
Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study 175
Motor cortex excitability in cerebellar ataxia. Clinical-neurophysiological correlations 175
EXTRATERRITORIAL SPREAD OF NEUROPATHIC PAIN SYMPTOMS IS FREQUENT IN PATIENTS WITH ULNAR NEUROPATHY AT THE ELBOW 174
VALIDAZIONE DI NUOVE TECNICHE STRUMENTALI PER LA VALUTAZIONE DEL CAMMINO E DEL “TURNING”: STUDIO SU 30 PAZIENTI CON MALATTIA DI PARKINSON 174
A 6-MONTH RANDOMIZED CONTROLLED TRIAL OF INTRAVENOUS IMMUNOGLOBULINS VERSUS INTRAVENOUS METHYLPREDNISOLONE IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (IMC STUDY) 173
Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction 173
Smoking-related cue reactivity in a virtual reality setting: association between craving and EEG measures 173
Rehabilitation and biomarkers of stroke recovery: study protocol for a randomized controlled trial 172
Ulnar nerve impairment at the wrist does not contribute to extramedian sensory symptoms in carpal tunnel syndrome. 171
Proximal pain in patients with carpal tunnel syndrome 171
The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study 171
Ulnar nerve impairment does not contribute to extramedian sensory symptoms in carpal tunnel syndrome 170
GOOD RESPONSE TO IVIG ADMINISTRATION IN A PATIENT WITH RELAPSING-REMITTING DIABETIC LUMBOSACRAL RADICULOPLEXUS NEUROPATHY 170
Neuropsychological testing 170
Totale 24.678
Categoria #
all - tutte 170.377
article - articoli 132.514
book - libri 0
conference - conferenze 35.058
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.805
Totale 340.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.346 0 0 0 0 189 127 57 135 70 46 130 592
2022/20234.842 299 392 433 798 372 1.058 105 345 571 88 267 114
2023/20243.190 160 209 278 318 342 395 202 288 94 270 389 245
2024/20256.874 448 367 383 1.084 368 295 402 375 876 437 573 1.266
2025/202619.569 1.367 1.053 1.751 3.064 4.569 1.221 1.841 1.123 1.489 1.107 454 530
2026/20276.604 2.262 827 874 2.631 10 0 0 0 0 0 0 0
Totale 51.922